The Society for Immunotherapy of Cancer (SITC) is the world's leading member-driven organization specifically dedicated to improving cancer patient outcomes by advancing the science and ...

"We look forward to the presentation of posters at ASH from across our product portfolio. We are very encouraged by the preliminary safety and efficacy data from our ongoing Phase 1b study of R289 ...

The upcoming live-action musical will be in good company when it comes to live-action anime adaptations. In recent years, anime fans in the West have been able to see the likes of Death Note and ...

allowing for control of tumors in vivo without the need for exogenous or engineered cytokines – – Posters include demonstration of advances in gene editing and transgene design that enable ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced ...

Valérie Plante said during a Radio-Canada talk show that aired Sunday night that the image of the woman wearing a hijab will ...

Victor A. Del Valle-Prieto's (BA Anthropology in Progress) poster, "Archaeology, Illustration, and the Importance of Trained Artists in the Field," won the Plains Anthropological Society's conference ...

TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / October 28, 2024 / CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biopharmaceutical company developing a new class of transformative medicines based o ...

today announced that the company will present two oral presentations and one poster presentation at the 66th American Society of Hematology (ASH) Annual Meeting, being held December 7-10, 2024, in San ...

- Initial data from the ongoing Phase 1b study evaluating R289, a dual IRAK1/4 inhibitor, in LR-MDS Initial data from the dose escalation phase using a July 15, 2024 data cutoff date indicate that ...

allowing for control of tumors in vivo without the need for exogenous or engineered cytokines- - Posters include demonstration of advances in gene editing and transgene design that enable greater ...